I just had the surreal conversation I thought I would have

New Post Public Reply Private Reply Replies (5) Message Board
Cassandra X Doctor580 #49064
1,002
I just had the surreal conversation I thought I would have with the CDC (Center for Disease Control).

I thought I would demonstrate to myself, yet once again, the curse of Cassandra at work in this crazy world. I have tried before to communicate to media, doctors and institutions, both government and private, a piece of information I thought they should know or pass along (amplify) to the public, society at large.

I'm just a guy trying to use his brain and, occasionally, come up with something interesting. For example, I confirmed early on, mostly from Dr. Gregory Poland, who is the head of Vaccine Research at the Mayo Clinic, that you can only catch the Covid-19 virus thru your mouth, your nose or your eyes. (Alright, anally too but I won't go there.) Wearing a mask, therefore, is an extremely important part of fighting the virus.

This was when the Surgeon General was screaming, "Don't wear masks!" I, of course, was not the only one pushing for people to wear masks but who would listen to me?

But the thing that really bugged me about this debate was that all the mask advocates were thinking of the masks as filters. They also wanted to say you needed a "good mask." I, on the other hand, wanted to weigh in and scream, "No, you do not need a great mask! People touch their faces constantly and any mask will tend to prevent you from contract transmission of the virus from your hands to your face! And any mask is better than nothing! Just look at the record of transmission in places that do wear masks!"

Only Dr. Poland responded to me out of my many outreach attempts to be heard by media, doctors and institutions. He said he agreed with me!

So tonight I decided to call up the CDC and have a chat with them about Cytodyn, Leronlimab, and, as Southern Gold and Doctor580 have called it, the most Effective drug Ever Tested against Covid-19 in a randomized, double-blinded drug trial.

I talked to a nice woman at the CDC. I asked her, "Does the CDC have an ombudsman?" She said, "How do you spell that?" .... "Nope, I did a search of the CDC data base and came up with nothing."

I said, "OK, will you do another search for me? Will you do a search for "Cytodyn"?" "Nope, nothing." "How about "Leronlimab"? I'll spell it." .... "Nope, nothing." Just as I suspected!

So then I prevailed on her to hear me out about a little company with a blockbuster anti-Covid-19 drug that the CDC doesn't seem to know about but probably should. She was intrigued and interested and took some notes and she said she would pass the information up to another level of bureaucracy and I should hear something by email in a day.

All of this went exactly as I thought it would.

This isn't conspiracy stuff, an evil invisible hand at work, Big Pharma, the Deep State, blah, blah, blah. It isn't even bureaucracy! It's just insularity! Doctors don't talk to doctors, family members won't listen to other family members who tell them to seek out "Leronlimab", institutions don't talk to other institutions, media "ain't got the time" to listen so only the loudest voices get heard. Everyone has their filters up. Nobody has ombudsman! The best way, and usually the only way, for small voice to be heard is thru connections. That's my experience.

So what do I want from the CDC? I want them to know about Cytodyn and Leronlimab, the best treatment for Covid-19 out there! I want it in there database for starters because they can't control disease if they don't even know about it! I want it to show up in the New York Times's "Treatment Tracker".

I want the CDC to say, "Where do we get some of this stuff? Why hasn't the National Institute of Health told us about this? Why hasn't Cytodyn gotten $1.6 Billion for their drug even tho they have fantastic results in their drug trials and Moderna has squat? What do you mean there is no manufacturing of this drug of any consiquence? What's the holdup?"

Connections! We have to keep trying to put a bug in the right person's ear. It's all most of us can do! Surreal!

If you do have someone who should hear about the Cytodyn and Leronlimab trials, the article at Targeted Oncology is a good one.

https://www.targetedonc.com/view/leronlimab-s...o-moderate








CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bravo Loans Bridge Gaps in Healthcare Real Estate

Updated Category News Views 70

Mezzanine Financing: A Vital Tool for Healthcare Owners Bravo Property Trust is throwing a lifeline to operators in the healthcare sector and beyond with their mezzanine loans aiming right between the eyes of the financing gap. This isn't just some loan for fun. It's a full-on financial tool designed to give some breathing room to folks owning or operating skilled nursing...

Continue Reading
$4 Million Raised at Miracles for Kids Gala 2026

Updated Category News Views 66

Anthony Geisler's Impactful Philanthropy Ever heard that old chestnut about putting your money where your mouth is? Well, Anthony Geisler, the chap behind Sequel Brands, sure seems to embody it. At the 2026 Miracles for Kids Night of Miracles Gala, he managed to corral over $4 million for families with critically ill kids. That's no chump change, let me tell you. The...

Continue Reading
FuelCell Energy Faces Legal Scrutiny After Stock Plunge

Updated Category News Views 56

FuelCell Energy's Troubling Stock Dive FuelCell Energy's recent plummet isn't just a sobering reality for traders—it comes wrapped in controversy. With NASDAQ:FCEL suffering a 15.69% nosedive after revelations from their fiscal third-quarter results, the ticker’s future hangs precariously. Even for those who've braved the market’s caprices, seeing shares drop $2.68...

Continue Reading
Membrane Chromatography Market Surges with Biologics Boom

Updated Category News Views 0

Another Chapter in Chromatography: What's New? It's like this: membrane chromatography is getting its day in the sun, and it's about time we dive into why it's happening. Projected to scale up from $0.37 billion in 2026 to a neat $0.63 billion by 2031, we’re talking a solid 11.3% compound annual growth rate. It's a tale of tech advancements and rising demand for...

Continue Reading
ACTEC Welcomes 55 New Fellows: A Closer Look

Updated Category News Views 115

Coffee's brewing hot, and so are the stakes at ACTEC, where 55 new Fellows just got the nod. The American College of Trust and Estate Counsel isn't your average club. They've been at this game since 1949, bringing together the finest minds in trusts and estates. But what does this newest batch bring to the table, and why should investors take a moment to notice? A Diverse...

Continue Reading
Geolava, Vaidio, Sensoneo Triumph in Texas Pitch Contest

Updated Category News Views 98

North Texas Lights the Innovation Torch Big moves are happening in North Texas, with a pitch competition that's more than just smoke and mirrors. We're talking about an arena where regional challenges meet cutting-edge solutions, and out of a global mix, Geolava, Vaidio, and Sensoneo snagged the 2026 North Texas Connected Innovation Pitch Contest crown. It's high stakes...

Continue Reading
ACR Poker's $650K Mystery PKO Tournaments Heat Up

Updated Category News Views 0

Final Countdown for ACR Poker’s Halloween Bash When it comes to poker, there might not be a better mix of tension and thrill than a big bounty tournament, and ACR Poker’s $650K Halloween Special Mystery PKOs are right in the thick of it. We’re down to the wire with just the final starting flights left, and the action’s ready to blow the lid off come November 1....

Continue Reading
Keller Joins JC Behavioral Health Council, RCA Shines

Updated Category News Views 50

RCA's Role in Behavioral Health Standards Kendall Keller just grabbed a prime seat at a table that could shape the future of behavioral healthcare in the U.S. Appointed to the Joint Commission’s (JC) Behavioral Health Care & Human Services Advisory Council, Keller isn’t lounging around. Here’s someone with 18 years under her belt, tasked with steering the ship for...

Continue Reading
Circus Circus Vegas Offers Halloween Deals for Families

Updated Category News Views 103

Halloween at Circus Circus: A New Spin on Family Fun Ah, Circus Circus Las Vegas. It's that place that’s managed to blend screaming kids, excited parents, and a flurry of flashing lights into something resembling an amusement park—on the Strip no less. Now, they're turning up the heat for Halloween. Yup, they're rolling out half-price Midway games and Adventuredome...

Continue Reading
Foxconn Shakes Up EV Scene with New Models Unveiled

Updated Category News Views 52

Foxconn Boldly Claims New Ground in EV Market Foxconn's at it again, thumping its chest in the electric vehicle arena with three fresh rides that scream ambition. At the HHTD26 in Taipei, they rolled out the MODEL A+, MODEL K+, and MODEL K—vehicles that not only diversify their portfolio but target segments that rarely see such a jolt. Does it get your gears turning?...

Continue Reading

Top 5 Most Recently Viewed Articles

Hewlett Packard Enterprise and Juniper Networks Stand Firm on Merger

Updated Category News Views 120

Hewlett Packard Enterprise and Juniper Networks Stand Firm Hewlett Packard Enterprise (NYSE:HPE) and Juniper Networks, Inc. (NYSE:JNPR) have publicly expressed their strong disapproval regarding the U.S. Department of Justice's recent move to block their impending acquisition. Both companies assert that the government's position is fundamentally misguided and look forward...

Continue Reading
Essity's Strategic Repurchase of Class B Shares Explained

Updated Category News Views 65

Essity’s Class B Shares Buyback Overview Recently, Essity Aktiebolag declared its intention to repurchase a significant quantity of its Class B shares. This initiative reflects the company's commitment to enhance its shareholders' value while efficiently managing capital allocation. The buyback program announced earlier provides a structured approach aimed at achieving...

Continue Reading
24 Seven Achieves Recognition on Forbes 2025 List of Best Firms

Updated Category News Views 253

24 Seven Achieves Recognition on Forbes 2025 List of Best Firms 24 Seven, a leading firm in the marketing, creative, and digital talent solutions space, has once again made waves in the industry by appearing on the prestigious list of America’s Best Recruiting and Temporary Staffing Firms for 2025. This significant recognition highlights the exemplary standards...

Continue Reading
Valneva's Chikungunya Vaccine Sees Strong Results in Children

Updated Category News Views 148

Positive Results from Valneva's Chikungunya Vaccine Trial Valneva SE (NASDAQ: VALN; Euronext Paris: VLA), a leading specialty vaccine company, has reported encouraging findings from its Phase 2 clinical trial for its chikungunya vaccine, IXCHIQ. This trial focused on assessing the safety and immunogenicity of two distinct dose levels of this single-shot vaccine among...

Continue Reading
Recognizing Trailblazers: 2025 WISE Awards Nominations Open

Updated Category News Views 368

Nominations Open for 2025 WISE Awards by Smart Energy Decisions Smart Energy Decisions (SED), a pivotal professional network focused on empowering businesses to make informed energy choices, has officially opened the nominations for the esteemed 2025 WISE (Women in Smart Energy) Awards. These awards aim to honor the groundbreaking contributions of women in the energy...

Continue Reading